Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The BioEscalator’s inaugural Pitch Battle contest was held digitally at the pizza social on Friday 17 April. Eleven pitches in total were delivered by innovative companies in Oxford's medical research district, covering the broad range of drug discovery, drug development and diagnostics work being undertaken at the BioEscalator.

Congratulations to MiroBio who won the overall best pitch prize with Juliane Schwaderer, Chris Lynch and Sara de Silva delivering a slick overview of their work on harnessing the immune system’s natural control mechanisms to combat auto-immune diseases.

Other prizes were awarded to Nucleome Therapeutics for best Covid-19 response, Ochre Bio’s Jack O’Meara for best speaker, BioArchitech for best video/graphics & best joke, Theolytics for most likely future unicorn, PepGen for best explanation of technology & Ervaxx for most mentions of the BioEscalator - well done to Andrew Fadden for cramming in as many as he did!

Four of these companies have now been put through to the Pitch Finale which will be held digitally on Friday 15 May in collaboration with BIO international and generously supported by Santander Universities UK. We’re looking forward to a great event.

Find out more about the BioEscalator

Similar stories

Can humans hibernate?

Illuminating new TEDx Talk from Professor of Sleep Physiology Vladyslav Vyazovskiy

Athena Swan Gold Award success for Nuffield Department of Primary Care Health Sciences

The award reflects the Department’s commitment to representation, progression and success for all. It acknowledges the innovative policies and practices developed across the department and the detailed action plans for improvement.

RECOVERY trial team awarded MRC Impact Prize for Outstanding Team Impact

The Medical Research Council Prize Committee has awarded the RECOVERY trial team the MRC Impact Prize 2022 for Outstanding Team Impact.

Professor Sir Chris Whitty brings greater understanding of epidemics to Oxford

Chief Medical Officer of England Professor Sir Chris Whitty KCB FMedSci delivers the Sherrington Prize Lecture: Public Understanding of Science to an audience of Oxford staff and students.

Multiple Debilitating Pains – New global study shows the experience of Endometriosis is rooted in a person’s genetics

Researchers at the University of Oxford in collaboration with 25 teams across the world have published the largest study to date of the genetic basis of endometriosis.

Study shows delaying treatment for localised prostate cancer does not increase mortality risk

Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind.